Beyond Air, Inc. (XAIR): Entry into a Material Definitive Agreement

Beyond Air, Inc. (XAIR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. The description in Item 5.02 below, as it relates to the terms and conditions of the Employment Agreement with Mr. Goodman, a copy of which is filed herewith as Exhibit 10.1, is incorporated herein by reference. Item 5.02. Dep

Event · Exec change
Person
Robert Goodman
Title
Chief Executive Officer
Effective
September 23, 2026

Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.

Original reporting
Published Sep 24, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$XAIR
Neutral
medium confidence
Mentioned
$XAIR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$XAIRNeutralLow
01

Why it matters

The filing is a routine corporate governance disclosure with limited market impact.

02

Market read

Primary disclosure of executive compensation; low trading relevance.

03

What to watch

Potential upcoming financing rounds may make compensation terms more material if dilution occurs.

Relevance 6/10Novelty 5/10Timing: filed Sep 24 2026

Background

Beyond Air is a micro‑cap aerospace company that recently appointed its CEO and adjusted CFO compensation.

Company-level read

Ticker impact

$XAIRNeutralMedium confidence
Context

Beyond Air disclosed a new employment agreement for CEO Robert Goodman with a $650,000 base salary and a CFO salary increase to $463,000.

Expected impact

minimal impact, potential slight upside if investors view leadership stability positively

Evidence & confidence

Compensation disclosures are routine; the amounts are modest relative to market cap, so price reaction is expected to be limited.

Market effects

Limited; executive pay updates do not materially affect the broader aerospace/defense sector.

None; the filing pertains only to Beyond Air's internal matters.

Low; no cross‑border implications.

Counterpoint

Investors could view the higher executive pay as a red flag for cash burn in a cash‑intensive startup.

Key entities

  • Robert Goodman

    Newly appointed CEO with a $650k base salary.

  • Daniel Moorhead

    CFO whose base salary was increased to $463k.

Related articles

$XAIRLow

Beyond Air Reports Financial Results and Provides Corporate Update

Beyond Air, Inc. (XAIR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Beyond Air Reports Financial Results and Provides Corporate Update for the Quarter Ended September 30, 2026 Record quarterly revenue of $2.3 million, representing approximately 28% year-over-year growth, reflecting continued adoption of first-generation LungFit PH PM

$XAIRMed

Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026

Beyond Air, Inc. (XAIR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Beyond Air ® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026 Preliminary revenue of $2.3 million represents the highest quarterly revenue reported, and approximately 30% sequential quarterly growth and 27% growth over the same period last ye

$XAIRMed

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Beyond Air, Inc. (XAIR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Beyond Air ® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update Reports $1.8 million revenue for quarter ended June 30, 2026; reaffirms revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 PMA supplement fo

$XAIRMed

Beyond Air, Inc. Q1 2027 Earnings Call Summary

Beyond Air, Inc. reported Q1 2027 revenue of $1.8 million, citing long hospital contracting cycles. Management said its sales pipeline doubled and secured a national GPO agreement. It reaffirmed 2026 revenue guidance of $8 million and projected 2027 revenue of $16-$18 million, tied to Gen II LungFit PH FDA timing. A $30 million financing supports Gen II launch.

$XAIRMed

Beyond Air (XAIR) Q1 2027 Earnings Call Transcript

Beyond Air (XAIR) held a Q1 2027 earnings call. It reported Q ended June 30, 2026 revenue of $1.8 million, flat vs the prior quarter, with gross margin rising to 13% from 9%. The company reaffirmed 2026 revenue guidance of $8 million and 2027 guidance of $16 million to $18 million, pending FDA approval for its Gen II LungFit PH system. It also entered a national GPO deal and announced financing up to $30 million.